A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2

Summary

Clinical trial looking at safety and efficacy of suvratoxumab in prevention of pneumonia caused by Staphylococcus aureus in high-risk patients

Timeline

Start

2022-09-02

Primary completion

2024-07-08

Completion

2024-07-08

Outcome

Outcome not reported

Stopped: “The study was terminated due to administrative reasons”

Drugs

Indications